Supernus Pharmaceuticals, Inc. (SUPN) Stock Price, Quote & AI Analysis
Live SUPN stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Supernus Pharmaceuticals, Inc..
TradeVae provides AI-driven analysis and real-time market intelligence for Supernus Pharmaceuticals, Inc. (SUPN), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Supernus Pharmaceuticals, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Supernus Pharmaceuticals, Inc. Overview
Company information
Company Overview
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Supernus Pharmaceuticals, Inc. Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...